Revised SPC: Sacubitril (vigabatrin) film-coated tablets and granules for oral solution

Section 4.4 and 4.8 have been updated with further information on risk of reduced visual acuity, and advice that both visual field testing and assessment of visual acuity should be done at treatment initiation and continued at 6 month intervals for whole duration of treatment.


electronic Medicines compendium